Since we mainly enrolled acral melanoma in our cohorts, which represents the most common subtype in Asians, it is reasonable to believe that CD73 may represent an ideal immunotherapy target next to PD-L1 in melanoma. The gene discussed is CD274; the disease is melanoma.